000			01933 a2200601 4500
005			20250517103511.0
264		0	_c20170127
008			201701s 0 0 eng d
022			_a1432-0584
024	7		_a10.1007/s00277-016-2745-4 _2doi
040			_aNLM _beng _cNLM
100	1		_aFaye, Blaise Felix
245	0	0	_aPattern of chronic myeloid leukemia in the imatinib era in a Sub-Saharan African setting. _h[electronic resource]
260			_bAnnals of hematology _cOct 2016
300			_a1603-10 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aChild
650	0	4	_aCost of Illness
650	0	4	_aDelayed Diagnosis
650	0	4	_aDeveloping Countries
650	0	4	_aDisease Management
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate _xtherapeutic use
650	0	4	_aKaplan-Meier Estimate
650	0	4	_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdiagnosis
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aNeoplasm Proteins _xantagonists & inhibitors
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aSenegal _xepidemiology
650	0	4	_aSocioeconomic Factors
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aDieng, Nata
700	1		_aSeck, Moussa
700	1		_aGadji, Macoura
700	1		_aGueye, Youssou Bamar
700	1		_aSy, Diariatou
700	1		_aToure, Sokhna Aissatou
700	1		_aSall, Abibatou
700	1		_aToure, Awa Oumar
700	1		_aDieye, Tandakha Ndiaye
700	1		_aDiop, Saliou
773	0		_tAnnals of hematology _gvol. 95 _gno. 10 _gp. 1603-10
856	4	0	_uhttps://doi.org/10.1007/s00277-016-2745-4 _zAvailable from publisher's website
999			_c26183948 _d26183948